vimarsana.com
Home
Live Updates
Soleno Therapeutics, Inc. announced that it expects to receive $59.89 million in funding from Abingworth LLP, Vivo Capital, LLC, Nantahala Capital Management, LLC, Brightleaf Capital, Corbin Capital Partners, L.P. : comparemela.com
Soleno Therapeutics, Inc. announced that it expects to receive $59.89 million in funding from Abingworth LLP, Vivo Capital, LLC, Nantahala Capital Management, LLC, Brightleaf Capital, Corbin Capital Partners, L.P.
Soleno Therapeutics, Inc. announced it has entered into a securities purchase agreement for a private placement of 22,600,000 common shares at a price of $2.65 per share for gross proceeds $59,890,000... |
Related Keywords
Manish Bhatnagar ,
James Mackaness ,
Soleno Therapeutics Inc ,
Blackwell Partners ,
Vivo Capital ,
Drug Administration ,
Nantahala Capital Management ,
Soleno Therapeutics ,
Abingworth Bioventures ,
Nantahala Capital Partners ,
Pinehurst Partners ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Soleno ,
Nnounced ,
It ,
Gas ,
Ntered ,
Into ,
Securities ,
Purchase ,
Agreement ,
Or ,
Private ,
Placement ,
F ,
Common ,
Hares ,
Price ,
Her ,
Phare ,
Cross ,
Roceeds Slno Us8342033094 ,
comparemela.com © 2020. All Rights Reserved.